FOXA1 is crucial in mediating the binding of ERα to its target genes, and whole genome ChIP-seq screening has demonstrated that FOXA1 plays a role in the reprogramming of ERα binding sites during breast cancer progression [23], [30]. This evidence concerns the gene FOXA1 and breast cancer.